PharmaCertify
 


Mobile Compliance
from PharmaCertify™


Ideal for distributing just-in-time information to field-based users, these devices can engage your employees with relevant content in context to their environment.

Follow PharmaCertify on Twitter      Read the PharmaCertify Blog

 


Commercial Compliance Commercial Compliance - Learn More
Managed Care - Learn More
Selling Skills - Learn More
In case you missed CBI’s 9th Annual Pharmaceutical Compliance Congress, our review, covering the insight and recommendations offered by your peers and government officials, has been posted to the PharmaCertify blog.
Top topics...

Understanding REMS
Educating various departments within your organization on risk management, and specifically on REMS, is essential for achieving success in today’s highly regulated marketplace.

MSLs and Sales Reps: Understanding the Divide
This module provides both MSLs and sales representatives with clear description of their responsibilities and clear lines of demarcation about who can discuss what with HCPs.

On-Label Promotion
Since off-label prescriptions may account for a large percentage of a drug’s sales, representatives must understand how to navigate this topic of discussion in a compliant manner. This module covers the rules around discussing off-label uses, including the high consequences of non-compliance, such as a recent $430 million penalty for one drug company.

State and Federal Spend and Disclosure Requirements
Learn the current disclosure regulations for all states and how to cope with the increasing number of large hospital-based healthcare systems that have restrictions and pharmaceutical sales activities.

Essentials of the Foreign Corrupt Practices Act
Learn how the bribery of “foreign officials” and the accounting practices that hide bribery come into play in relation to the business of selling drugs and medical devices.

Commercial Compliance Overview
Commercial Compliance Overview helps sales representatives stay in compliance by describing what types of sales incentives, promotional activities and detailing discussions are prohibited.

From our Twitter Feed

ALL CONTENTS © COPYRIGHT 2007-2011 NXLevel Solutions. ALL RIGHTS RESERVED  -  Privacy Policy